Shares of Medtronic are benefiting from an improved ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...

Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

According to Diabetotech on LinkedIn, the first patch pump could hold 300 units of insulin with a 7-day wear time. It integrates Medtronic’s existing extended-wear infusion set For the next-generation ...

Medtronic's MiniMed 670G - the closest thing ... loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device ...

It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...